A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors
Clinical trial NCT02880371 · TERMINATED
Trial details
- NCT number
- NCT02880371
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-09-17
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.